Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Revenue (2016 - 2025)

Veracyte's Revenue history spans 14 years, with the latest figure at $140.6 million for Q4 2025.

  • For Q4 2025, Revenue rose 18.55% year-over-year to $140.6 million; the TTM value through Dec 2025 reached $517.1 million, up 16.01%, while the annual FY2025 figure was $517.1 million, 16.01% up from the prior year.
  • Revenue for Q4 2025 was $140.6 million at Veracyte, up from $131.9 million in the prior quarter.
  • Across five years, Revenue topped out at $140.6 million in Q4 2025 and bottomed at $36.7 million in Q1 2021.
  • The 5-year median for Revenue is $90.2 million (2023), against an average of $92.0 million.
  • The largest annual shift saw Revenue skyrocketed 166.16% in 2021 before it increased 13.75% in 2025.
  • A 5-year view of Revenue shows it stood at $67.3 million in 2021, then rose by 19.25% to $80.3 million in 2022, then increased by 22.29% to $98.2 million in 2023, then grew by 20.81% to $118.6 million in 2024, then grew by 18.55% to $140.6 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Revenue are $140.6 million (Q4 2025), $131.9 million (Q3 2025), and $130.2 million (Q2 2025).